Effect of Positive Therapeutic Communication on Pain (POPAIN)

August 28, 2024 updated by: Christophe Le Terrier, Hôpital Fribourgeois

Effect of POsitive Therapeutic Communication on PAIN and Anxiety During Arterial Blood Gas Standardized Procedures in the Emergency Department Compared With Traditional Communication: a Monocentric Randomized Controlled Trial

Pain, defined as a disagreeable sensory or emotional experience, is the most frequent symptom among patients admitted to the emergency department (ED). It is estimated that this symptom can be observed in almost 80% of patients upon their arrival to the ED. Despite several international recommendations concerning pain management, pain in the context of an emergency situation often remains underestimated. Medical procedures, such as venous or arterial blood collection, which are essential for diagnostic management and patient care, can also generate pain and a high level of stress for patients who are already weakened by their underlying condition. This is known as "care-related pain".

Arterial blood gas (ABG) sampling is necessary to assess the gravity of the patient's condition and is a procedure conducted routinely in the ED. In a medium-size hospital (30,000 hospitalizations per year), approximately 1000 ABG tests are conducted annually. However, ABG collection is generally associated with pain and patient anxiety.

In order to decrease the perception of pain linked to the collection of arterial blood, several methods have been studied, such as applying a topical anesthetic cream (lidocaine, xylocaine) or a subcutaneous infection of lidocaine prior to the procedure. Given that ABG collection is often performed in emergency situations and that the anesthetic cream must be applied at least one hour before sampling, this method is not adapted to emergency practices. In a previous study, a subcutaneous injection of lidocaine did not allow to significantly reduce pain during radial artery puncture. Similarly, another study using ultrasound guidance for ABG sampling did not show any significant decrease in pain, the rate of immediate complications, or physician satisfaction.

Apart from the therapeutic tools commonly used, communication is a key element of care. In routine practice, caregivers inform patients that they are going to perform a potentially painful act. However, forewarning a patient that one will perform a painful act increases the perception of pain. It has also been shown that a communication strategy including the use of positive, kind or reassuring terms ("let me reassure you…", "are you comfortable?", "are you warm enough?") can contribute to decreasing the pain, while conversely, the choice of terms with a negative connotation ("okay, this might sting", "don't panic", "are you in pain?", "are you cold?") may increase the perception of pain and provoke a sense of discomfort. In the latter case, this is known as the "nocebo" effect. A communication strategy including reassuring terms, perceived by the brain as an agreeable information, allows to decrease the penibility dimension or connotes otherwise the pain in order to make it more bearable, thus modulating the painful perception. The objective of this strategy is that the painful message becomes less present as much as possible and that the patient benefits from a feeling of control. This procedure is widely used in hypnosis communication and is based on a neurobiological rationale, i.e., an increase in the secretion of endogenous opioids affecting the pain modulation networks decreases transmission in the pain pathways, thus leading to a release of dopamine in the striatum. This technique has already shown to be of benefit in patient management in various domains, such as anesthesia and pediatrics.

Arrival at the ED can induce a particular state of consciousness linked to anxiety and a heightened suggestibility of negative communication. Although several studies have compared the impact of verbal attitudes, notably in the domain of anesthesia and mainly with staff already trained in hypnosis, to our knowledge, none has studied the effect of positive communication by caregivers or physicians among a patient population in the ED setting. Given the limited therapeutic options to relieve the pain and discomfort of blood collection performed in the ED, we would like to evaluate in this study the potential benefit of positive therapeutic communication on pain and anxiety among patients who require ABG compared to nocebo or neutral communication.

Study Overview

Study Type

Interventional

Enrollment (Actual)

279

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Fribourg, Switzerland, 1700
        • Firbourg Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients over 18 years of age.
  • Patients scheduled to undergo radial ABG collection during their visit to the ED to allow to pursue routine care.
  • Free and informed consent of the patient received orally from one of the study investigators at study entry.

Exclusion Criteria:

  • Vital emergency requiring immediate resuscitation
  • Patients incapable of judgement.
  • Patients with conditions that render them unable to participate in the intervention of the present study, e.g., cognitive impairment, major hearing loss without the use of hearing aids, acute psychiatric disorders, under intravenous or oral sedation.
  • Patients with an insufficient understanding of the French language as defined by self-evaluation.
  • Local anesthesia (subcutaneous, transdermal patch) at the point of ABG puncture.
  • Patients already treated with anxiolytics or sedatives during care at the ED.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Positive Therapeutic communication
The procedure of arterial blood collection will be conducted in a seated position for all three groups. The patient is in a supine position, with the forearm comfortably placed on a small table. The needle used for blood collection is a 25 gauge needle without local anesthetic. This method of sampling is identical to the one used in daily practice in the Emergency department of Fribourg
Active Comparator: Nocebo communication
The procedure of arterial blood collection will be conducted in a seated position for all three groups. The patient is in a supine position, with the forearm comfortably placed on a small table. The needle used for blood collection is a 25 gauge needle without local anesthetic. This method of sampling is identical to the one used in daily practice in the Emergency department of Fribourg
Active Comparator: Neutral communication
The procedure of arterial blood collection will be conducted in a seated position for all three groups. The patient is in a supine position, with the forearm comfortably placed on a small table. The needle used for blood collection is a 25 gauge needle without local anesthetic. This method of sampling is identical to the one used in daily practice in the Emergency department of Fribourg

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Pain
Time Frame: Change of Pain at 3 minutes after the procedure from baseline
Self-evaluation of maximum pain felt by the patient during collection of an ABG sample on a Verbal Rating Scale (VRS) (0 = no pain - 10 = worst imaginable pain)
Change of Pain at 3 minutes after the procedure from baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Comfort
Time Frame: Change of Comfort at 3 minutes after the procedure from baseline
Self-evaluation of patient comfort using a simple comfort VRS (0 = no comfort - 10 = most comfortable imaginable)
Change of Comfort at 3 minutes after the procedure from baseline
Change of Anxiety
Time Frame: Change of Anxiety at 3 minutes after the procedure from baseline
Self-evaluation of patient anxiety using a simple anxiety VRS (0 = no anxiety - 10 = the worst anxiety imaginable)
Change of Anxiety at 3 minutes after the procedure from baseline
Puncture failure
Time Frame: at 3 minutes after the procedure
The success of the first arterial puncture will be assessed by the accredited evaluator at the end of the procedure by the number of puncture points visible on the patient's skin. Possible response: one puncture visible, yes/no.
at 3 minutes after the procedure
Global satisfaction with the communication strategy used
Time Frame: at 3 minutes after the procedure
Evaluation by the patient at the end of the procedure using a numeric scale of 0 to 10 (0 = extremely dissatisfied - 10 = extremely satisfied).
at 3 minutes after the procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2023

Primary Completion (Actual)

August 28, 2024

Study Completion (Actual)

August 28, 2024

Study Registration Dates

First Submitted

June 13, 2022

First Submitted That Met QC Criteria

June 22, 2022

First Posted (Actual)

June 27, 2022

Study Record Updates

Last Update Posted (Actual)

August 30, 2024

Last Update Submitted That Met QC Criteria

August 28, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Effect of Positive Therapeutic Communication on Pain

Clinical Trials on Arterial Blood Gas

Subscribe